TransMIT
Leading German technology transfer office facilitating AM adoption through government-accredited innovation management, funding advisory, and specialized bionics networks.
- CEO / Founder
- Dr. Peter Stumpf
- Team Size
- 51-200
- Stage
- Active
- Total Funding
- $0.48M
- Latest Round
- Grant
- Key Investors
- BMWK; BAFA; Hessian Ministry of Science and Art; Justus-Liebig-Universität Gießen; Technische Hochschule Mittelhessen; Philipps-Universität Marburg
Technology & Products
Key Products
TransMIT GmbH provides technology transfer services to customers in the pharmaceutical/medical, biotechnology, chemical, automotive, plant and mechanical engineering sectors.
Technological Advantage
Direct access to IP from three major Hessian universities and a structured process for SME funding.
Differentiation
Value Proposition
Enables SMEs to de-risk AM adoption by securing up to 50% federal funding for R&D projects while providing direct access to university-level IP and cross-industry bionics expertise.
How They Differentiate
Unlike pure consultancies, TransMIT is a university-owned entity with official BMWK/BAFA accreditation, allowing them to directly manage federal grants and university IP portfolios for AM applications.
Market & Competition
Target Customers
German SMEs and research institutions seeking AM commercialization.
Industry Verticals
Industrial; Medical; Aerospace; Automotive
Competitors
Steinbeis-Stiftung; Fraunhofer IAPT; AMPOWER
Growth & Milestones
Growth Metrics
Annual revenue of approximately $8M in 2024; manages a network of 7,000+ scientists and 170+ employees.
Major Milestones
Founded 1996; Ranked #1 German tech transfer company; Launch of 3D Printing & Bionics network
Notable Customers
Sangui BioTech; SMEs in the Mittelhessen region